These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7786326)

  • 21. Contribution of a new, rapid, individual and quantitative automated D-dimer ELISA to exclude pulmonary embolism.
    de Moerloose P; Desmarais S; Bounameaux H; Reber G; Perrier A; Dupuy G; Pittet JL
    Thromb Haemost; 1996 Jan; 75(1):11-3. PubMed ID: 8713772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac biomarkers in pulmonary embolism.
    Lippi G; Favaloro EJ
    Thromb Haemost; 2008 Jun; 99(6):1134-6. PubMed ID: 18521526
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparative analysis of D-dimer assays in patients with clinically suspected pulmonary embolism.
    van Beek EJ; van den Ende B; Berckmans RJ; van der Heide YT; Brandjes DP; Sturk A; ten Cate JW
    Thromb Haemost; 1993 Sep; 70(3):408-13. PubMed ID: 8259539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-dimer determination to exclude pulmonary embolism: a two-step approach using latex assay as a screening tool.
    de Moerloose P; Minazio P; Reber G; Perrier A; Bounameaux H
    Thromb Haemost; 1994 Jul; 72(1):89-91. PubMed ID: 7974382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performances of a new, rapid and automated microlatex D-dimer assay for the exclusion of pulmonary embolism in symptomatic outpatients.
    Reber G; Bounameaux H; Perrier A; de Moerloose P
    Thromb Haemost; 1998 Oct; 80(4):719-20. PubMed ID: 9799007
    [No Abstract]   [Full Text] [Related]  

  • 26. Prediction rules and POC D-dimer testing as a way to prevent diagnostic delay of fatal pulmonary embolism.
    Klemenz B
    Br J Gen Pract; 2016 Oct; 66(651):513. PubMed ID: 27688502
    [No Abstract]   [Full Text] [Related]  

  • 27. The physician's estimation 'alternative diagnosis is less likely than pulmonary embolism' in the Wells rule is dependent on the presence of other required items.
    Klok FA; Zidane M; Djurabi RK; Nijkeuter M; Huisman MV
    Thromb Haemost; 2008 Jan; 99(1):244-5. PubMed ID: 18217165
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of a D-dimer as a screening test in the emergency department.
    Strane N; Propp DA
    Ann Emerg Med; 2006 May; 47(5):506; author reply 507. PubMed ID: 16631995
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical probability and D-dimer testing: how should we use them in clinical practice?
    Hargett CW; Tapson VF
    Semin Respir Crit Care Med; 2008 Feb; 29(1):15-24. PubMed ID: 18302083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-dimer measurement and laboratory feedback.
    Lippi G; Favaloro EJ
    J Emerg Med; 2009 Jul; 37(1):82-3; author reply 83. PubMed ID: 19168310
    [No Abstract]   [Full Text] [Related]  

  • 31. Strategies for the diagnosis of deep vein thrombosis and pulmonary embolism.
    Chunilal SD; Ginsberg JS
    Thromb Res; 2000 Jan; 97(1):V33-48. PubMed ID: 10668807
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fibrin-fibrinogen degradation products (F.D.P.) in thromboembolism and other diseases].
    Jones DR; Webber A; Prescott RJ; Allan NC; Ruckley CV
    Vasa; 1976; 5(4):332-7. PubMed ID: 1007541
    [No Abstract]   [Full Text] [Related]  

  • 33. The rehabilitation of clinical assessment for the diagnosis of pulmonary embolism.
    Michiels JJ; Berghout A; Schroyens W; De Backer W; Hoogsteden H; Pattynama PM
    Semin Vasc Med; 2002 Nov; 2(4):345-51. PubMed ID: 16222624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of a rapid D-dimer blood test in the diagnostic work-up for pulmonary embolism: a management study.
    de Groot MR; van Marwijk Kooy M; Pouwels JG; Engelage AH; Kuipers BF; Büller HR
    Thromb Haemost; 1999 Dec; 82(6):1588-92. PubMed ID: 10613639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACEP releases clinical policy on evaluation and management of pulmonary embolism.
    Neff MJ;
    Am Fam Physician; 2003 Aug; 68(4):759-60. PubMed ID: 12952389
    [No Abstract]   [Full Text] [Related]  

  • 36. D-dimer testing for PE.
    Mohs JC; Newton WP
    J Fam Pract; 1997 Dec; 45(6):466-7. PubMed ID: 9420574
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonary embolism. ANTELOPE-Study Group.
    Mac Gillavry MR; de Monyé W; Lijmer JG; Nieuwenhuizen W; Büller HR; Huisman MV; Brandjes DP
    Thromb Haemost; 2000 Jun; 83(6):892-5. PubMed ID: 10896244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [D-dimer determination in suspected deep venous thrombosis or lung embolism].
    Bounameaux H
    Praxis (Bern 1994); 1997 Nov; 86(47):1860-4. PubMed ID: 9480504
    [No Abstract]   [Full Text] [Related]  

  • 39. LDH and fibrinogen-fibrin degradation products in pulmonary embolism.
    Light RW; Bell WR
    Arch Intern Med; 1974 Mar; 133(3):372-5. PubMed ID: 4283737
    [No Abstract]   [Full Text] [Related]  

  • 40. Different accuracies of rapid enzyme-linked immunosorbent, turbidimetric, and agglutination D-dimer assays for thrombosis exclusion: impact on diagnostic work-ups of outpatients with suspected deep vein thrombosis and pulmonary embolism.
    Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; De Maeseneer M; Hermsen JT; Trienekens PH; Hoogsteden H; Pattynama PM
    Semin Thromb Hemost; 2006 Oct; 32(7):678-93. PubMed ID: 17024595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.